Keay Wu

Keay Wu is an experienced professional in quality systems and operations within the pharmaceutical industry, currently serving as Associate Director of Quality Systems at Exelixis since April 2021, where responsibilities include overseeing the CAPA program. Prior to this role, Keay has held significant positions at BioMarin Pharmaceutical Inc. as Senior Manager of Quality Operations and Senior Manager of QATS Deviation/CAPA. Keay's previous experience includes a role in QA Validation at Boehringer Ingelheim, management of QC departments at Baxalta, and extensive work in environmental quality assurance and change management at Bayer HealthCare and Chiron/Novartis. Keay holds a Bachelor’s degree in Microbiology from San Francisco State University.